A January 17th Securing Industry article noted that the FDA has been awarded a patent on the fake drug detector they developed with Corning Inc. in 2013. The battery-powered handheld device, dubbed CD-3, employs optical wavelength testing to identify counterfeit drugs and packaging. Customs officers use it as an initial screening device at various entry ports in the United States.
Companies in this article